Taken together, our findings identify a regulatory mechanism by which AR upregulates KLF4 expression directly and transcriptionally; subsequently, KLF4 increases miR-1 expression levels and sustains suppressed prostate tumorigenesis. The gene discussed is KLF4; the disease is medical procedure.